Blog
RSS FeedPosted by Michael Wonder on 22 Jun 2016
Health Canada's approval of Taltz (ixekizumab) brings targeted therapy to Canadians living with moderate-to-severe plaque psoriasis
21 June 2016 - Eli Lilly Canada announced today that Health Canada has granted approval for Taltz (ixekizumab) for the treatment ...
Posted by Michael Wonder on 21 Jun 2016
FDA approves new drug application for Rayaldee to treat secondary hyperparathyroidism associated with vitamin D insufficiency in stage 3-4 chronic kidney disease
21 June 2016 - U.S. launch planned for 2H 2016. ...
Posted by Michael Wonder on 21 Jun 2016
Agreement with Smith & Nephew for the supply of orthopaedic trauma implants
21 June 2016 - PHARMAC is pleased to announce the approval of an agreement with Smith and Nephew for the supply ...
Posted by Michael Wonder on 20 Jun 2016
TGA approves new indication for Glypressin (terlipressin acetate)
20 June 2016 - The TGA has approved a new indication for Ferring Pharmaceuticals' Glypressin (terlipressin acetate). ...
Posted by Michael Wonder on 18 Jun 2016
Drug combination for treating skin cancer approved for NHS use
17 June 2016 - Medicines regulator NICE moves at record speed to approve nivolumab for use with ipilimumab in melanoma patients. ...
Posted by Michael Wonder on 16 Jun 2016
Sacubitril with valsartan in heart failure: differentiated value added
16 June 2016 - Addendum results in a revised benefit assessment for patients with type 2 diabetes mellitus. ...
Posted by Michael Wonder on 16 Jun 2016
NICE publishes appraisal consultation for cobimetinib hemifumarate (Cotellic) for patients with malignant melanoma
16 June 2016 - NICE has published an appraisal consultation for Roche's cobimetinib hemifumarate (Cotellic). ...
Posted by Michael Wonder on 16 Jun 2016
Updated NICE quality standard identifies areas for breast cancer improvement
15 June 2016 - NICE’s latest quality standard published today says people who have been diagnosed with a type of early ...
Posted by Michael Wonder on 16 Jun 2016
Roche’s Gazyvaro approved in Europe in combination with bendamustine for people with previously treated follicular lymphoma
16 June 2016 - This is the second approval in Europe for Gazyvaro based on a positive phase III study. ...
Posted by Michael Wonder on 16 Jun 2016
Shire and Kamada announce FDA approval of expanded label for self-infusion of Glassia for the treatment of emphysema due to severe AAT deficiency
15 June 2016 - Glassia is the only FDA approved alfa-1 antitrypsin (human) augmentation treatment that patients can self-infuse at home. ...
Posted by Michael Wonder on 15 Jun 2016
Osimertinib mesylate in lung cancer: no assigned additional benefits
15 June 2016 - No direct comparative studies / effects in historical comparisons too small for statements for additional benefits. ...
Posted by Michael Wonder on 15 Jun 2016
Orfadin 20 mg capsules approved in the US
15 June 2016 - Swedish Orphan Biovitrum AB (Sobi) announced today that the FDA has approved a higher strength 20 mg ...
Posted by Michael Wonder on 15 Jun 2016
Health Canada approves Inflectra (biosimilar Infliximab) for three additional indications: Crohn's disease, fistulising Crohn's disease and ulcerative colitis
14 June 2016 - Hospira today announced that Inflectra (biosimilar infliximab) has been approved by Health Canada for three additional indications, ...
Posted by Michael Wonder on 14 Jun 2016
FDA approves AspireAssist obesity device
14 June 2016 - The U.S. FDA today approved a new obesity treatment device that uses a surgically-placed tube to drain ...
Posted by Michael Wonder on 14 Jun 2016
NICE recommends laser device to help thousands of men with an enlarged prostate
14 June 2016 - Thousands of men could benefit from laser treatment for an enlarged prostate as recommended in new guidance ...